Industry Watch
•  Agenix Limited Annual Results
•  Axon's Strategy Does the Trick
•  Pro Medicus Records Strong Profit Performances
•  AstraZeneca Launches Nexium in China
•  Beijing Shuanglu Pharma Markets Recombinant Human Interleukin-II
•  Shanghai Squibb Launches Tequin
•  Shanghai Wanxing Biopharma to Conduct Clinical Trials on Malaria Vaccine
•  Cipla Registers Anti-AIDS Drugs in South Africa
•  NDDB Commercializes Rabies Vaccine
•  ITRI and HP Collaborate in System Biology Bioinformatics Project
•  GlaxoSmithKline Plans to Establish R&D Facility in Taiwan

Products/Services Highlight
•  "Living" Bandages from CellTran
•  New Deep Purple Total Protein Stain Enhances Sensitivity in Protein Detection
•  Amersham Biosciences’ Latest CodeLink Human P450 SNP Bioarray for Broad-based Toxicogenomic Screening

Research Findings
•  Japanese Researchers Made Progress in Stem Cells Research
•  New Genetic-based Predictive Models for Lung Cancer Relapse
•  Alcohol Doubles the Chance of Colon Cancer
•  Taiwanese Researchers Discover Rare Skin Disease Genes
•  GM Tobacco Plant Model for Rabies Antibody Production

Agriculture
•  AusBiotech 2003 Key Session: Genetic Selection and Improved Nutrition in Animal Production
•  Japan Approves Transgenic Rice Commercial Planting
•  Golden Rice Shows Promise in Philippines
•  Brazil Reverses Ruling on GM Soybeans
•  GM Cottonwood Offer Remediation for Mercury Contamination
•  United Nations Highlights the Role of New Biotechnology

Commentaries & Analyses
•  China's Cephalosporin Market
•  Obesity in Asian Womens’ Eyes:
Results of Study Underscore Huge Potential for Weightmanagement Industry

General News
•  Australia's First Macadamia Biomass Cogeneration Plant
•  The 37th National New Drug Trade Fair in China
•  New Lung Cancer Drug Available in Singapore
•  Bio-Pharma Dominate Biotech Market
•  Mammography X-Ray Units Fail to Meet Standards in Japan
•  DCB and Academia Sinica in Partnership for Biotechnology Development

Global Development
•  Agendia Leverages on Agilent Technologies’ Gene Expression Platform for Development of First Microarray-Based Breast Cancer Test

Education
•  Singapore-UK Bioinformatics Education Program

People
•  World-renowned Cancer Specialist - Yoshiaki Ito

Conference Calendar